Heron Therapeutics
HRTX
#7836
Rank
A$0.41 B
Marketcap
$2.70
Share price
0.58%
Change (1 day)
-35.63%
Change (1 year)

EPS for Heron Therapeutics (HRTX)

EPS in 2023 (TTM): -$1.76

According to Heron Therapeutics's latest financial reports the company's current EPS (TTM) is -$1.83. In 2022 the company made an earnings per share (EPS) of -$2.70 an increase over its 2021 EPS that were of -$3.51.

EPS history for Heron Therapeutics from 1996 to 2023

Annual EPS

Year EPS Change
2023 (TTM)-$1.76-34.7%
2022-$2.70-23.11%
2021-$3.51-10%
2020-$3.90-0%
2019-$3.901.21%
2018-$3.86-32.7%
2017-$5.73-19.34%
2016-$7.1054.76%
2015-$4.591.73%
2014-$4.51-16.23%
2013-$5.3991.67%
2012-$2.81-31.45%
2011-$4.10-27.06%
2010-$5.62-43.75%
2009-$9.99-57.33%
2008-$23.42-82.92%
2007-$137.1020.61%
2006-$113.68175.76%
2005-$41.22-21.43%
2004-$52.47100%
2003-$26.23-38.24%
2002-$42.47161.54%
2001-$16.24-106.46%
2000$251.242051.55%
1999$11.68839.73%
1998$1.24-105.48%
1997-$22.69-88.16%
1996-$191.66

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
$2.03-211.11%๐Ÿ‡ฎ๐Ÿ‡ช Ireland
$0.22-111.97%๐Ÿ‡บ๐Ÿ‡ธ USA
-$2.55 39.32%๐Ÿ‡บ๐Ÿ‡ธ USA
$2.45-234.19%๐Ÿ‡บ๐Ÿ‡ธ USA
-$2.58 41.03%๐Ÿ‡บ๐Ÿ‡ธ USA